Top Markets
#1 DogBull DogBull +105.24%
#2 ADO Protocol ADO Protocol +63.57%
#3 Siacoin Siacoin +46.50%
#4 MarsCoin MarsCoin +37.49%
#5 Useless Coin Useless Coin +36.09%
#6 UnifAI Network UnifAI Network +27.18%
#7 Ontology Gas Ontology Gas +26.56%
#8 Falcon Finance Falcon Finance +17.20%
#9 Apertum Apertum +14.82%
#10 Magma Finance Magma Finance +12.76%
Coin of the day
DogBull DogBull
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Guhan Pharmaceutical Group Co., Ltd. Guhan Pharmaceutical Group Co., Ltd.

Guhan Pharmaceutical Group Co., Ltd.

000590
Kedudukan dalam Saham #15808
Guhan Pharmaceutical Group Co., Ltd., along with its various subsidiaries,... Guhan Pharmaceutical Group Co., Ltd., along with its various subsidiaries, operates as a prominent Chinese pharmaceutical enterprise. The company focuses on the production and distribution of traditional Chinese medicine (TCM), conventional chemical pharmaceuticals, and health supplements within the domestic market. Its business activities are organized into specific segments, including the manufacturing and sale of traditional Chinese medicine, the manufacturing and sale of Western medicine, and a range of other operations. The company boasts a comprehensive product catalog featuring both prescription and over-the-counter (OTC) drugs. This selection includes tonics and health-boosting preparations, medications for cardiovascular and cerebrovascular conditions, nutritional products for children, cold and flu remedies, and detoxifying agents. Beyond its core manufacturing, Guhan Pharmaceutical is involved in a diverse array of additional services and ventures. These encompass health and nutrition advisory services, the cultivation of Chinese medicinal herbs, extensive medical research and experimental development, planning for cultural and artistic exchanges, general medical consultations, online sales, technology promotion, consulting agent services, outpatient care, and comprehensive pharmaceutical wholesale and retail operations. Founded in 1956, the company is headquartered in Hengyang, China. It was previously known as Tus-Pharmaceutical Group Co., Ltd., officially adopting its current name, Guhan Pharmaceutical Group Co., Ltd., in November 2025.
Harga Saham
$1.37
Modal Pasaran
$328.98M
Perubahan (1 hari)
0.64%
Perubahan (1 tahun)
-20.55%
Negara
CN
Perdagangan Guhan Pharmaceutical Group Co., Ltd. (000590)

Kategori

Healthcare
Pendapatan untuk Guhan Pharmaceutical Group Co., Ltd. (000590)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Guhan Pharmaceutical Group Co., Ltd., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Guhan Pharmaceutical Group Co., Ltd. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US